This New Company Believes Psychedelics Can Treat Dementia
There is currently no known cure for dementia, but Return Health CEO Dr. James Kuo says psychedelics offer “unprecedented” potential.
There is currently no known cure for dementia, but Return Health CEO Dr. James Kuo says psychedelics offer “unprecedented” potential.
Recent study interviews 23 underground psychedelic therapy practitioners about the biggest ethical issues and boundary challenges they face while sharing such an intimate space with clients.
This week in psychedelic business news: Cybin inhales; atai Life Sciences expands; DEA grants new psilocybin license; and FDA backs ketamine.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.